In 457 autopsies of cases with non-Hodgkin's malignant lymphoma tumour cardiac lesion was found in 43 (9.4%) observations; 5 of them with a combination of tumour with post infarctional myocardial sclerosis were excluded from the analysis. The clinical-anatomic data from 38 autopsies were divided into 3 groups: marked insignificant and only microscopically revealed tumour lesion of the myocardium. No correlations between the degree of morphological changes and clinical-electrographic picture were found. The distribution of some clinical and morphologic features of myocardial lesion depending on the histologic tumour type is presented according to "Working Formulation", 1982. Myocardial lesion was noted predominantly in non-Hodgkin's malignant lymphomas with a high degree of malignancy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

non-hodgkin's malignant
8
myocardial lesion
8
[various clinico-anatomic
4
clinico-anatomic variants
4
variants heart
4
heart lesions
4
lesions lymphosarcoma]
4
lymphosarcoma] 457
4
457 autopsies
4
autopsies cases
4

Similar Publications

Bispecific antibodies (BsAb) have emerged as a leading treatment modality in patients suffering from B-cell non-Hodgkin's lymphoma (B-NHL). However, treatment failure is common and may potentially be attributed to pre-existing or emerging T-cell exhaustion. CD39 catalyzes-together with CD73-the hydrolysis of immunogenic ATP into immunosuppressive adenosine and thus actively promotes an immunosuppressive micromilieu.

View Article and Find Full Text PDF

Introduction: Burkitt lymphoma (BL) is a rare and aggressive subtype of non-Hodgkin's lymphoma. Several studies have identified prognostic factors (PFs) for disease progression and mortality among adults with BL. However, there is no consensus on risk stratification based on PFs.

View Article and Find Full Text PDF

Purpose: This study aims to identify and summarize evidence on the effectiveness of exercise-based interventions on muscle mass, muscle strength, functional performance, aerobic capacity, health-related quality of life (HRQoL), feasibility of the interventions, in patients with malignant lymphoma undergoing chemotherapy.

Methods: A systematic search was conducted in six electronic databases and trials registers on November 15, 2023. Peer-reviewed randomized controlled trials (RCTs) comparing exercise intervention with controls/usual care in adults (≥18 years) diagnosed with Hodgkin's lymphoma and non-Hodgkin's lymphoma undergoing chemotherapy were considered for inclusion.

View Article and Find Full Text PDF

Chimeric antigen receptor T cell (CAR-T) therapies are now standard-of-care for several B-cell malignancies, and additional indications are being evaluated. In this review, we survey data on how outcomes after CAR-T therapies vary according to age, race, and ethnicity. We also review the representation of age, racial, and ethnic groups in key CAR-T clinical trials.

View Article and Find Full Text PDF

Background: Research into the intratumoral microenvironment in lymphoma has been escalated along with improved survival and new targeted therapies with an intent to refine risk stratification and prognostication. Various studies have reported significance of quantitative DCE-MRI parameters for predicting biological behaviour of various tumors. This study is an endeavour to supplement the existing literature on quantitative DCE-MRI in nodal lymphoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!